Jilin Huisheng Biopharmaceutical
Privately held: no public share price · China
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
janagliflozin(Huiyoujing) | Phase 3 | SGLT2Small molecule | Type 2 DiabetesChronic Kidney Disease |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.